25 April 2023
27 January 2021
GLOBAL SURVEY ON ACCESS TO AND QUALITY OF HIV CARE AND TREATMENT – LEBANON & MOR…
The International Treatment Preparedness Coalition (ITPC) conducted its first Global HIV Treatment Access Survey in 2018 to assess the current state of HIV/AIDS care and treatment services in 14 countries and to document the
12 September 2018
Call for application : MENA-CAB meeting 2018
Are you advocates of the right to health and access to treatment? or activist living with HIV, hepatitis C, hepatitis B or tuberculosis in the North Africa and Middle East (MENA) region? Would you
15 January 2018
GSIPA2M streaming
PATHWAYS TO ACCESS 15-17 January 2018 MARRAKESH – MOROCCO
26 October 2017
New Study : Assessment of national intellectual property landscapes and their impact …
Title: A tool to assess how friendly to access-to-medicines your law is Background Provisions of intellectual property (IP) may have an important impact on access to medicines. For instance, the monopoly granted by the
15 October 2017
ITPC-MENA organize its Middle East and North Africa Community Advisory board (MENACAB…
The International Treatment Preparedness Coalition in Middle East and North Africa (ITPC-MENA) is organizing its Middle East and North Africa Community Advisory board (MENACAB), in late November in Marrakech.The MENACAB is a treatment advocate network
21 September 2017
ITPC-MENA at the Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017)
ITPC-MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) Join ITPC-MENA at AFRAMED 2017 – Hammamet Join ITPC_MENA at 2nd Mediterranean Symposium on HIV and Hepatitis (AFRAMED 2017) in Tunis and Hammamet from
14 September 2017
2nd Francophone Symposium AFRAMED on HIV and Hepatitis
2nd Francophone Symposium AFRAMED on HIV and Hepatitis September 28 to 30, Hammamet, Tunisie Following the success of the first experience in Algeria, the second edition of AFRAMED symposium will be hosted by Tunisia.
26 July 2017
IAS 2017: Closing ceremony exposes Gilead Sciences
Conference funders, Gilead Sciences, named and shamed for its “insatiable greed” Yesterday, the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), drew to a close, in style. The community address delivered
24 July 2017